BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 31806053)

  • 1. Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies.
    Wagner NB; Weide B; Gries M; Reith M; Tarnanidis K; Schuermans V; Kemper C; Kehrel C; Funder A; Lichtenberger R; Sucker A; Herpel E; Holland-Letz T; Schadendorf D; Garbe C; Umansky V; Utikal J; Gebhardt C
    J Immunother Cancer; 2019 Dec; 7(1):343. PubMed ID: 31806053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-1,3-Galactosyl-
    Sumardika IW; Youyi C; Kondo E; Inoue Y; Ruma IMW; Murata H; Kinoshita R; Yamamoto KI; Tomida S; Shien K; Sato H; Yamauchi A; Futami J; Putranto EW; Hibino T; Toyooka S; Nishibori M; Sakaguchi M
    Oncol Res; 2018 Apr; 26(3):431-444. PubMed ID: 28923134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.
    Ruma IM; Putranto EW; Kondo E; Murata H; Watanabe M; Huang P; Kinoshita R; Futami J; Inoue Y; Yamauchi A; Sumardika IW; Youyi C; Yamamoto K; Nasu Y; Nishibori M; Hibino T; Sakaguchi M
    Clin Exp Metastasis; 2016 Aug; 33(6):609-27. PubMed ID: 27151304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100A8/A9 activate key genes and pathways in colon tumor progression.
    Ichikawa M; Williams R; Wang L; Vogl T; Srikrishna G
    Mol Cancer Res; 2011 Feb; 9(2):133-48. PubMed ID: 21228116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of mRNA, Protein, and Urinary Nucleic Acid Levels of S100A8 and S100A9 between Prostate Cancer and BPH.
    Yun SJ; Yan C; Jeong P; Kang HW; Kim YH; Kim EA; Lee OJ; Kim WT; Moon SK; Kim IY; Choi YH; Kim WJ
    Ann Surg Oncol; 2015 Jul; 22(7):2439-45. PubMed ID: 25348783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100A8 and S100A9 in Cancer.
    Chen Y; Ouyang Y; Li Z; Wang X; Ma J
    Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188891. PubMed ID: 37001615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma cell adhesion molecule is the driving force behind the dissemination of melanoma upon S100A8/A9 binding in the original skin lesion.
    Chen Y; Sumardika IW; Tomonobu N; Winarsa Ruma IM; Kinoshita R; Kondo E; Inoue Y; Sato H; Yamauchi A; Murata H; Yamamoto KI; Tomida S; Shien K; Yamamoto H; Soh J; Liu M; Futami J; Sasai K; Katayama H; Kubo M; Putranto EW; Hibino T; Sun B; Nishibori M; Toyooka S; Sakaguchi M
    Cancer Lett; 2019 Jun; 452():178-190. PubMed ID: 30904617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newly developed anti-S100A8/A9 monoclonal antibody efficiently prevents lung tropic cancer metastasis.
    Kinoshita R; Sato H; Yamauchi A; Takahashi Y; Inoue Y; Sumardika IW; Chen Y; Tomonobu N; Araki K; Shien K; Tomida S; Torigoe H; Namba K; Kurihara E; Ogoshi Y; Murata H; Yamamoto KI; Futami J; Putranto EW; Ruma IMW; Yamamoto H; Soh J; Hibino T; Nishibori M; Kondo E; Toyooka S; Sakaguchi M
    Int J Cancer; 2019 Jul; 145(2):569-575. PubMed ID: 30414170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observational study on Swedish plaque psoriasis patients receiving narrowband-UVB treatment show decreased S100A8/A9 protein and gene expression levels in lesional psoriasis skin but no effect on S100A8/A9 protein levels in serum.
    Duvetorp A; Söderman J; Assarsson M; Skarstedt M; Svensson Å; Seifert O
    PLoS One; 2019; 14(3):e0213344. PubMed ID: 30865695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100A8/A9 in Inflammation.
    Wang S; Song R; Wang Z; Jing Z; Wang S; Ma J
    Front Immunol; 2018; 9():1298. PubMed ID: 29942307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histidine-Rich Glycoprotein Suppresses the S100A8/A9-Mediated Organotropic Metastasis of Melanoma Cells.
    Tomonobu N; Kinoshita R; Wake H; Inoue Y; Ruma IMW; Suzawa K; Gohara Y; Komalasari NLGY; Jiang F; Murata H; Yamamoto KI; Sumardika IW; Chen Y; Futami J; Yamauchi A; Kuribayashi F; Kondo E; Toyooka S; Nishibori M; Sakaguchi M
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia and HIF-1 increase S100A8 and S100A9 expression in prostate cancer.
    Grebhardt S; Veltkamp C; Ströbel P; Mayer D
    Int J Cancer; 2012 Dec; 131(12):2785-94. PubMed ID: 22505354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100a8/a9 released by CD11b+Gr1+ neutrophils activates cardiac fibroblasts to initiate angiotensin II-Induced cardiac inflammation and injury.
    Wu Y; Li Y; Zhang C; A X; Wang Y; Cui W; Li H; Du J
    Hypertension; 2014 Jun; 63(6):1241-50. PubMed ID: 24711518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of myofibroblasts in upregulation of S100A8 and S100A9 and the differentiation of myeloid cells in the colorectal cancer microenvironment.
    Kim JH; Oh SH; Kim EJ; Park SJ; Hong SP; Cheon JH; Kim TI; Kim WH
    Biochem Biophys Res Commun; 2012 Jun; 423(1):60-6. PubMed ID: 22634002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. exMCAM-Fc, an S100A8/A9-mediated-metastasis blocker, efficiently reduced the number of circulating tumor cells that appeared in the blood flow.
    Tomonobu N; Kinoshita R; Sakaguchi M
    Mol Biol Rep; 2020 Jun; 47(6):4879-4883. PubMed ID: 32383137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100A8/A9: a Janus-faced molecule in cancer therapy and tumorgenesis.
    Ghavami S; Chitayat S; Hashemi M; Eshraghi M; Chazin WJ; Halayko AJ; Kerkhoff C
    Eur J Pharmacol; 2009 Dec; 625(1-3):73-83. PubMed ID: 19835859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100A8/A9 in Myocardial Infarction.
    Sreejit G; Nooti SK; Athmanathan B; Nagareddy PR
    Methods Mol Biol; 2019; 1929():739-754. PubMed ID: 30710308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100A8/A9 promotes parenchymal damage and renal fibrosis in obstructive nephropathy.
    Tammaro A; Florquin S; Brok M; Claessen N; Butter LM; Teske GJD; de Boer OJ; Vogl T; Leemans JC; Dessing MC
    Clin Exp Immunol; 2018 Sep; 193(3):361-375. PubMed ID: 29746703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100A8/A9 Induced by Interaction with Macrophages in Esophageal Squamous Cell Carcinoma Promotes the Migration and Invasion of Cancer Cells via Akt and p38 MAPK Pathways.
    Tanigawa K; Tsukamoto S; Koma YI; Kitamura Y; Urakami S; Shimizu M; Fujikawa M; Kodama T; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
    Am J Pathol; 2022 Mar; 192(3):536-552. PubMed ID: 34954212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proinflammatory Proteins S100A8/S100A9 Activate NK Cells via Interaction with RAGE.
    Narumi K; Miyakawa R; Ueda R; Hashimoto H; Yamamoto Y; Yoshida T; Aoki K
    J Immunol; 2015 Jun; 194(11):5539-48. PubMed ID: 25911757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.